Links between pharmacological properties of retinoids and nuclear retinoid receptors.
Bollag
W
W
Pharma Research, F. Hoffmann-La Roche Ltd., Basel, Switzerland.
Isnardi
L
L
Jablonska
S
S
Klaus
M
M
Majewski
S
S
Pirson
W
W
Toma
S
S
D017209:Apoptosis / Q000187:drug effects*; D001565:Benzoates / Q000494:pharmacology; D002454:Cell Differentiation / Q000187:drug effects*; D002455:Cell Division / Q000187:drug effects*; D002839:Chromans / Q000494:pharmacology; D018922:HL-60 Cells / Q000187:drug effects; D006801:Humans; D009389:Neovascularization, Pathologic / Q000517:prevention & control*; D018168:Receptors, Retinoic Acid / Q000819:agonists / Q000037:antagonists & inhibitors / Q000502:physiology*; D047488:Retinoid X Receptors; D012176:Retinoids / Q000378:metabolism / Q000494:pharmacology*; D014157:Transcription Factors / Q000819:agonists / Q000037:antagonists & inhibitors / Q000502:physiology*
D001565:Benzoates; D002839:Chromans; D018168:Receptors, Retinoic Acid; D047488:Retinoid X Receptors; D012176:Retinoids; D014157:Transcription Factors; C084904:Ro 41-5253